GGrantIndex
Sort

46,585 grants matching heart failure

Adding Inspiratory Muscle Training to Optimize Cardiac Rehabilitation for Heart Failure

$745,851
Joshua R. Smith · Mayo Clinic Rochester · R01 · FY2025 · HL

STEPPED CARE FOR DEPRESSION IN HEART FAILURE

$745,830
Kenneth E Freedland · Washington University · R01 · FY2016 · HL

Evaluating Resolution Mechanisms for Infectious Inflammation

$745,800
Charles Nicholas Serhan · Brigham And Women'S Hospital · R35 · FY2025 · GM

Evaluating Resolution Mechanisms for Infectious Inflammation

$745,800
Charles Nicholas Serhan · Brigham And Women'S Hospital · R35 · FY2022 · GM

Evaluating Resolution Mechanisms for Infectious Inflammation

$745,800
Charles Nicholas Serhan · Brigham And Women'S Hospital · R35 · FY2023 · GM

Evaluating Resolution Mechanisms for Infectious Inflammation

$745,800
Charles Nicholas Serhan · Brigham And Women'S Hospital · R35 · FY2024 · GM

Microbubble-Medicated Ultrasonic Therapy for Microvascular Obstruction

$745,737
John J Pacella · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · HL

Reagentless Sensor Technologies For Continuous Monitoring of Heart Failure Biomarkers

$745,727
Shana O Kelley · Northwestern University · R01 · FY2024 · HL

Seeking Objectivity in Allocation of Advanced Heart Failure (SOCIAL HF) Therapies Trial

$745,724
Khadijah Breathett · Indiana University Indianapolis · R01 · FY2022 · HL

ECMO without Anticoagulation

$745,721
Alvaro Rojas-Pena · University Of Michigan At Ann Arbor · R01 · FY2023 · HL

Synchronous Valveless Pulsatile Support Device for the Failing Heart

$745,711
Richard Warren Smalling · Windmill Cardiovascular Systems, Inc. · R42 · FY2014 · HL

Novel Roles for IRE1 in Regulating Cardiac Fibrosis

$745,663
Erik Blackwood · Utah State Higher Education System--University Of Utah · R01 · FY2025 · HL

Enhancement of an Artificial Lung for Ambulatory Respiratory Support

$745,655
Bartley Perry Griffith · University Of Maryland Baltimore · R01 · FY2021 · HL

Characterization and Genetics of KI toxicity in iPSC-derived cardiomyocytes

$745,632
Ulrich Broeckel · Medical College Of Wisconsin · R01 · FY2019 · HL

Novel therapeutic approach for severe ARDS with a potent pharmacologic allosteric hemoglobin modifier

$745,621
David Richard Light · Illexcor Therapeutics, Llc · R44 · FY2023 · HL

Multi-Scale Laws of Myocardial Growth and Remodeling

$745,554
Julius Matteo Guccione · University Of California, San Francisco · U01 · FY2018 · HL

Elucidating hereditary transthyretin-mediated heart failure risk using machine learning, polygenic risk and recall by genotype approaches in African ancestry individuals

$745,525
Ron Do · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · HL

Bioengineering Mature Human Pluripotent Stem Cell-Derived Cardiomyocytes for Predictive Drug-Induced Toxicity Testing

$745,488
Nicholas Andrew Geisse · Curi Bio Inc · R44 · FY2021 · HL

Molecular examination of mitochondrial calcium control

$745,476
Jeffery D Molkentin · Cincinnati Childrens Hosp Med Ctr · R01 · FY2019 · HL

Pathogenic hotspots illuminate mechanism and therapeutic potential in arrhythmogenic cardiomyopathy

$745,470
Victoria Parikh · Stanford University · R01 · FY2024 · HL

4D Multimodal Image-Based Modeling for Bicuspid Aortic Valve Repair Surgery

$745,417
Alison Marie Pouch · University Of Pennsylvania · R01 · FY2022 · HL

Discovery of Novel Pharmaceutical Agents for Skeletal Muscle Atrophy

$745,404
Scott Matthew Ebert · Emmyon, Inc. · R44 · FY2020 · AR

Discovery of Novel Pharmaceutical Agents for Skeletal Muscle Atrophy

$745,404
Scott Matthew Ebert · Emmyon, Inc. · R44 · FY2021 · AR

Regulation of Chromatin Signaling in Heart Failure by the BRD4 Bromodomain Protein.

$745,398
Timothy McKinsey · University Of Colorado Denver · R01 · FY2020 · HL

Regulation of Chromatin Signaling in Heart Failure by the BRD4 Bromodomain Protein.

$745,398
Timothy McKinsey · University Of Colorado Denver · R01 · FY2021 · HL